R

RELX

Global information analytics and decision tools

Audit & Risk Management Specialist 1

Full-TimeUpdated on 10/15/2026
No salary listed
Mid, Senior
Bachelor's
Manila, Metro Manila, Philippines
In Person
AccountingFinancial Accounting

About the job

Requirements
  • A bachelor's degree in Accounting, Finance, or a related field is required.
  • Four to six years of relevant experience in external audit, statutory reporting, financial reporting compliance, tax compliance support, or finance shared services is required.
  • Strong knowledge of accounting standards, statutory financial reporting, audit requirements, taxation principles, and financial statement preparation is required.
  • A good understanding of end-to-end finance processes, including Record to Report, Procure to Pay, and Order to Cash, and their effects on financial reporting and controls is required.
  • Advanced skills in reviewing balance sheet reconciliations, audit schedules, management reports, trial balance analytics, and complex account balances are required.
  • The candidate must be able to apply professional skepticism, identify risks or control gaps, ask effective questions, and recommend practical solutions.
  • Strong stakeholder management, communication, and interpersonal skills are required to work effectively with auditors, tax agents, business partners, and cross-functional finance teams.
  • The candidate must be highly organized, detail-oriented, and able to manage multiple priorities and deadlines in a fast-paced environment.
  • Strong Microsoft Excel skills are required.
  • The candidate must be able to quickly learn and apply enterprise AI tools and technologies to support technical workflows and business objectives.
  • The candidate must be able to manage audit, statutory reporting, tax support, and compliance deliverables with minimal supervision while maintaining accuracy and timeliness.
Responsibilities
  • Develop and deliver financial guidelines and protocols to support regulatory compliance and good financial practice.
  • Conduct research using primary data sources and select information needed to analyze key themes and trends.
  • Deliver audit assignments in nominated client areas by developing individual audit plans and detailed scopes, conducting fieldwork, reporting findings and opinions, agreeing corrective actions with auditees, and referring serious or contentious issues to the lead auditor.
  • Contribute to preparing data and analytics reports.
  • Advise managers on applying existing procedures and precedents.
  • Identify team instances of noncompliance with organizational policies, procedures, regulatory codes, or codes of conduct; report and escalate issues as appropriate.
  • Build personal capabilities through assessment and development planning, training, and coaching; maintain relevant professional accreditation; and stay informed about technology, external regulation, and industry best practices through ongoing education, conferences, and specialist media.
  • Coordinate and support the annual external audit process, including preparing, reviewing, and tracking audit deliverables, statutory accounts, and supporting schedules to meet RELX and local regulatory deadlines.
  • Prepare, review, and analyze statutory financial statements, disclosure notes, regulatory reporting requirements, tax packs, indirect tax reporting schedules, transfer pricing support, and other compliance-related submissions for in-scope entities.
  • Perform financial statement review procedures, including trial balance analytics, balance sheet reconciliation quality checks, audit schedule reviews, exposure summaries, and investigations of unusual variances or accounting issues.
  • Work with Finance teams, business units, tax agents, external auditors, internal auditors, and other stakeholders to resolve accounting, audit, tax, statutory reporting, and compliance queries in a timely and professional manner.
  • Support internal control effectiveness by identifying control gaps, process risks, audit findings, and compliance issues, and recommending practical remediation or mitigation actions.
  • Contribute to SOX, internal controls, audit readiness, process documentation, and compliance reviews, ensuring evidence, narratives, schedules, and supporting files are complete, accurate, and organized.
  • Drive continuous improvement, standardization, and automation opportunities across statutory reporting, audit coordination, financial review, tax compliance support, and related finance processes.
  • Provide technical guidance, training, and knowledge sharing to accountants and finance stakeholders on local regulatory requirements, accounting standards, audit expectations, and RELX accounting policies and practices.
  • Demonstrate ownership, sound judgment, professional skepticism, and follow-through in managing deadlines, resolving issues, escalating risks, and supporting high-quality compliance outcomes.
Desired Qualifications
  • CPA or an equivalent professional qualification is preferred.
  • Big 4 audit experience, multinational company experience, or finance shared services/BPO experience is highly preferred.
  • Experience with enterprise accounting systems such as Oracle, SAP, PeopleSoft, or similar platforms is an advantage.

About the company

RELX is a global provider of information-based analytics and decision tools for professionals across scientific, technical, medical, legal, risk, business, and exhibitions industries. It operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. Its products combine large datasets, analytics, and decision-support tools to help researchers, healthcare professionals, lawyers, and business leaders make informed choices, improve productivity, and achieve better outcomes. Revenue mainly comes from subscriptions, with additional income from transactional sales and advertising. RELX differentiates itself through its deep data assets, specialized industry knowledge, and multi-segment offerings that span content, analytics, and decision-support services. The company pursues a goal of delivering trusted information and insights while supporting corporate responsibility and alignment with the UN SDGs through its products and partnerships.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

London, United Kingdom

Founded

1894

Get referred to RELX

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 revenue grew 7%; Legal grew 10%; Risk grew 8%.
  • February 24, 2026 Lexis+ with Protégé launched globally, expanding AI workflow adoption.
  • September 3, 2026 Doctrine closes, targeting one million European legal professionals.

What critics are saying

  • Anthropic and Thomson Reuters compressed legal AI pricing after February 2026 market shock.
  • Harvey and Legora court law schools in 2026, training future buyer cohorts elsewhere.
  • Exhibitions face Middle East event uncertainty through 2026, threatening margins and calendar-dependent cash flows.

What makes RELX unique

  • LexisNexis’ 200 billion-document corpus still beats generic legal AI models.
  • September 3, 2026 Doctrine acquisition deepens RELX’s European legal AI workflow moat.
  • H1 2026 subscriptions supplied 62% of revenue, stabilizing cash generation.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Mental Health Support

Family Planning Benefits

Health Savings Account/Flexible Spending Account

Flexible Work Hours

Remote Work Options

Company News

Citybiz
Apr 28th, 2026
RELX to Acquire Legaltech Platform Doctrine in European AI Push

RELX Group has entered into an agreement to acquire French legal technology company Doctrine, a move that would expand its... Read More

Business Insider
Mar 1st, 2026
LexisNexis CEO dismisses AI threat as company reports 7% revenue growth

LexisNexis CEO Sean Fitzpatrick has dismissed investor concerns that AI threatens the legal software giant, saying proprietary data gives it a competitive advantage. Shares of parent company Relx fell 14% on 3 February following Anthropic's launch of an AI agent that drafts legal briefs, and are down 17% year-to-date. Fitzpatrick said LexisNexis's database of 200 billion legal documents, including content from Shepard's Citations dating to 1873, cannot be replicated by AI model makers. The company doesn't license its proprietary data to general-purpose AI providers. Relx reported 7% revenue growth for 2025 and 9% increase in adjusted operating profit, driven by customers adopting AI tools. LexisNexis is hiring and hasn't conducted AI-related redundancies.

Yahoo Finance
Feb 22nd, 2026
RELX's LexisNexis launches AI-powered identity management platform for healthcare

LexisNexis Risk Solutions, a wholly owned subsidiary of RELX, has launched a new identity management platform for the healthcare sector. Announced on 19 February, the tool combines identity verification, matching and enrichment capabilities with AI-powered authentication to enhance security throughout patients' healthcare journeys. The platform integrates LexisNexis IDVerse and offers enhanced identity verification, resolution and fraud protection. For healthcare professionals, it accelerates onboarding processes, automates processing and provides digital checks to prevent fraud. RELX is a global information and analytics company serving professional and business customers across scientific, technical, medical, legal and risk management markets.

PR Newswire
Jun 4th, 2025
Elsevier Unveils Rigorous Evaluation Framework To Mitigate Risk In Generative Ai Clinical Decision Support Tools

Clinician-centered framework will be featured in upcoming issue of the Open AccessJournal of the American Medical Informatics Association (JAMIA)Initial evaluations of ClinicalKey AI show high accuracy and usefulness in responses amongst cliniciansNEW YORK, June 4, 2025 /PRNewswire/ -- Elsevier, a global leader in medical information and data analytics, unveiled a groundbreaking evaluation framework for assessing the performance and safety of generative AI-powered clinical reference tools. This innovative approach has been developed for all Elsevier Health generative AI solutions, including ClinicalKey AI, Elsevier's advanced clinical decision support platform, and sets a new standard for responsible AI integration in healthcare. It will be featured in a future issue of the Open Access Journal of the American Medical Informatics Association (JAMIA).The framework, designed with input from clinical subject matter experts across multiple specialties, evaluates AI-generated responses along five critical dimensions: query comprehension, response helpfulness, correctness, completeness, and potential for clinical harm. It serves as a comprehensive assessment to ensure that AI-powered tools not only provide accurate and relevant information but also align with the practical and current needs of healthcare professionals at the point of care.Omry Bigger, President of Clinical Solutions at Elsevier: "This evaluation framework not only supports innovation and advancements to improve patient care but adds an extra layer of review and assessment to ensure physicians are armed with the most accurate information possible. It's a critical step in the implementation of responsible AI for healthcare providers and patients."In a recent evaluation study of ClinicalKey AI, Elsevier worked with a panel of 41-board certified physicians and clinical pharmacists to rigorously test responses generated by the tool for a diverse set of clinical queries. That panel evaluated 426 query-response pairs, and results demonstrated impressive performance, with 94.4% of responses rated as helpful, 95.5% assessed as completely correct, with just 0.47% flagged for potential improvements.Leah Livingston, Director of Generative AI Evaluation for Health Markets at Elsevier, said: "These results reflect not just strong performance, but the real value of bringing clinicians into the evaluation process

PharmiWeb
May 7th, 2025
Elsevier Adds Half A Million Records From Clinicaltrials.Gov To Embase, Enabling A Seamless Search Experience In The World’S Most Comprehensive Biomedical Database

London, 6 May 2025 – Elsevier, a global leader in information and analytics, is announcing the addition of half a million records from ClinicalTrials.gov to its leading biomedical literature database, Embase. The integration will enable researchers to seamlessly view high-quality information on clinical research studies and their results alongside the peer-reviewed literature, in-press publications and conference abstracts already available in Embase. Researchers will be able to conduct more comprehensive evidence and literature searches while having the confidence they will never miss important updates relevant to their drug, therapy, or medical device. Clinical trials data is a vital component of biomedical literature search, helping pharmaceutical and medical device companies stay informed about the latest scientific advancements, regulatory requirements, and competitive insights to support evidence-based decision-making. However, gathering data from multiple sources is currently prone to errors and is time-consuming, such as the duplication of search results, which slows research and regulatory processes. As new therapies and devices are developed and RD organizations seek collaborative partners, they must undertake thorough searches and justifications of evidence